Company attributes
Location
B2X
Date Incorporated
2020
Number of Employees (Ranges)
11 – 50
Email Address
info@abintus.com
applications@abintus.com
info@abintusbio.com
Full Address
10355 Science Center Dr Ste 250 San Diego, CA, 92121-1158 United States
CIK Number
Investors
Founded Date
2020
Total Funding Amount (USD)
15,652,623
Latest Funding Round Date
August 15, 2022
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
15,652,623
Abintus Bio, Inc. is a preclinical stage gene therapy company that focuses on discovering and developing a portfolio of product candidates that are designed to directly reprogram immune cells from their native environment using proprietary vectors.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
